Paraoxonase 1 gene polymorphisms contribute to coronary artery disease risk among north Indians

Indian Journal of Medical Sciences

Volumn 63, Issue 8, 2009, Pages 335-344

  Agrawal, S ^a   Tripathi, Gaurav ^a   Prajnya, R ^a   Sinha, Nakul ^a   Gilmour, A ^b   Bush, L ^b   Mastana, S ^b  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

Aryldialkylphosphatase; Coronary artery disease; Genetic; Genetic predisposition to disease; Genetics; Genotype; Human; Polymorphism; PON1 protein

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1;

ADULT; ALLELE; ANGIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHI SQUARE TEST; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; ETHNICITY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; INDIAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SEX DIFFERENCE; SMOKING;

ARYLDIALKYLPHOSPHATASE; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY DISEASE; GENE FREQUENCY; GENOTYPE; HUMANS; INDIA; LOGISTIC MODELS; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK;

EID: 70349938011     PISSN: 00195359     EISSN: 19983654     Source Type: Journal    
DOI: 10.4103/0019-5359.55884     Document Type: Article

References (42)

1. Tobin MD, Braund PS, Burton PR, Thompson JR, Steeds R, Channer, et al. Genotypes and haplotypes predisposing to myocardial infarction: A multilocus case-control study. Eur Heart J 2004;25:459-467 (Pubitemid 38524270)
2. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, et al. Genomewide association analysis of coronary artery disease. N Engl J Med 2007;357:443-453 (Pubitemid 47204873)
3. Ashavaid TF, Shalia KK, Kondkar AA, Todur SP, Nair KG, Nair SR. Gene polymorphism and coronary risk factors in Indian Populations. Clin Chem Lab Med 2002;40:975-985
4. Hirashiki A, Yamada Y, Murase Y, Suzuki Y, Kataoka H, Morimoto Y, et al. Association of gene polymorphisms with coronary artery disease in low or high risk subjects defined by conventional risk factors. J Am Coll Cardiol 2003;42:1429-1437 (Pubitemid 37267286)
5. Enas EA. Coronary artery disease epidemics in Indians: A cause for alarm and call for action. J Indian Med Assoc 2000;98:697-702.
6. Singh RB, Tomlinson B, Thomas N, Sharma R. Coronary artery disease and coronary risk factors: The south Asian paradox. J Nutr Environ Med 2001;11:43-51. (Pubitemid 32281109)
7. Agrawal S, Singh VP, Tewari S, Sinha N, Ramesh V, Agarwal S, et al. Angiotensin-converting enzyme gene polymorphism in coronary artery disease in north India. Indian Heart J 2004;56: 44-46 (Pubitemid 38525373)
8. Girisha KM, Gilmour A, Mastana S, Singh VP, Sinha N, Tewari S, et al. T1 and M1 polymorphism in glutathione S-transferase gene and coronary artery disease in North Indian population. Indian J Med Sci 2004;58:520-526
9. Sankar VH, Girisha KM, Gilmour A, Singh VP, Sinha N, Tewari S, et al. TNFR2 gene polymorphism in coronary artery disease. Indian J Med Sci 2005;59:104-108 (Pubitemid 40545118)
10. Banerjee I, Pandey U, Hasan OM, Parihar R, Tripathi V, Ganesh S. Association between inflammatory gene polymorphisms and coronary artery disease in an Indian population. J Thromb Thrombolysis 2009;27:88-94.
11. Rai TS, Khullar M, Sehrawat BS, Ahuja M, Sharma PK, Vijayvergiya R, et al. Synergistic effect between apolipoprotein E and apolipoprotein A1 gene polymorphisms in the risk for coronary artery disease. Mol Cell Biochem 2008;313:139-146
12. Sharda S, Gilmour A, Harris V, Singh VP, Sinha N, Tewari S, et al. Chemokine receptor 5 (CCR5) deletion polymorphism in North Indian patients with coronary artery disease. Int J Cardiol 2008;124:254-258 (Pubitemid 351173353)
13. Singh PP, Singh M, Bhatnagar DP, Kaur TP, Gaur SK. Apolipoprotein E polymorphism and its relation to plasma lipids in coronary heart disease. Indian J Med Sci 2008;62:105-112
14. Mackness B, Mackness MI, Arrol S, Turkei W, Durrington PN. Effect of the human serum paraoxonase 55 and 192 genetic polymorphism on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 1998;423:57-60. (Pubitemid 28098579)
15. Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN. The human serum paraoxonase / arylesterase gene (PON1) is one member of a multigene family. Genomics 1996;33:498-507. (Pubitemid 26159866)
16. Humbert R, Disteche CM, Hasset C, Omiecinski CJ, Furlong CE. The molecular basis of the human serum Paraoxonase activity polymorphism. Nat Genet 1993;3:73-76 (Pubitemid 23063292)
17. Senti M, Tomas M, Marrugat J, Elosua R. Paraoxonase 1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLs. Arterioscler Thromb Vasc Biol 2001;21:415. (Pubitemid 32199124)
18. Scacchi R, Corbo RM, Rickards O, De Stefano, GF. New data on the world distribution of paraoxonase (PON1 192) gene frequencies. Hum Biol 2003;75:365-373
19. Ruiz J, Blanche H, James RW, Blatter Garin MC, Vaisee C, Charpentier G, et al. Gln-Arg 192 polymorphism of Paraoxonase and coronary heart disease in type 2 diabetes. Lancet 1995;30:869-872
20. Odawara M, Tachi Y, Yamashita K. Paraoxonase polymorphism (Gln192Arg) is associated with coronary heart disease in Japanese Non insulin dependent diabetes mellitus. J Clin Endocr Metab 1997;82:2257-2260 (Pubitemid 27287594)
21. Ferre N, Tous M, Paul A, Zamora A, Vendrell JJ, Bardaji A, et al. Paraoxonase Gln-Arg(192) and Leu-Met(55) gene polymorphisms and enzyme activity in a population with a low rate of coronary heart disease. Clin Biochem 2002;35:197-203.
22. Robertson KS, Hawe, E, Miller GJ, Talmud PJ, Humphries SE. Human Paraoxonase gene cluster polymorphisms as predictors of coronary heart disease risk in the prospective Nortwick Park Heart Study II. Biochem Biophysica Acta 2003;1639:203-212 (Pubitemid 37421428)
23. Pfohl M, Koch M, Enderle MD, Kuhn R, Fullhase J, Karsch KR, et al. Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes. Diabetes 1999;48:623-627 (Pubitemid 29106879)
24. Sanghera DK, Saha N, Aston CE, Kamboh MI. Genetic polymorphisms of Paraoxonase and the risk of coronary heart disease. Arterioscler Thromb Vasc Biol 1997;17:1067-1073 (Pubitemid 27260325)
25. Sanghera DK, Saha N, Kamboh MI. The codon 55 polymorphism in the paraoxonase 1 gene is not associated with the risk of coronary heart disease in Asian Indians and Chinese. Atherosclerosis 1998;136:217-223 (Pubitemid 28133409)
26. Pati N, Pati U. Paraoxonase gene polymorphism and coronary artery disease in Indian subjects. Int J Cardiol 1998;66:165-168 (Pubitemid 29052342)
27. Serrato M, Marian AJ. A variant of human paraoxonase/ arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J Clin Investig 1995;96:3005-3008
28. Bhattacharyya T, Nicholls SJ, Topol EJ, Zhang R, Yang X, Schmitt D, et al. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA 2008;299:1265-1276
29. Hong SH, Song J, Min, WK, Kin, JK. Genetic variations of the Paraoxonase gene in patients with coronary artery disease. Clin Biochem 2001;34:475-481 (Pubitemid 33001317)
30. Ombres D, Pannitteri G, Montali A, Candeloro A, Seccareccia F, Campagna F, et al. The gln- Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in Italian patients. Arterioscler Thromb Vasc Biol 1998;18:1611-1616 (Pubitemid 28465414)
31. Lawlor DA, Day IN, Gaunt TR, Hinks LJ, Briggs PJ, Kiessling M, et al. The association of the PON1 Q192R polymorphism with coronary heart disease: Findings from the British Women.s Heart and Health cohort study and a meta-analysis. BMC Genet 2004;5:17. (Pubitemid 41363886)
32. Balcerzyk A, Zak I, Krauze J. Synergistic effects between Q192R polymorphism of paraoxonase 1 gene and some conventional risk factors in premature coronary artery disease. Arch Med Res 2007;38:545-550 (Pubitemid 46873816)
33. Wheeler JG, Keavney BD, Watkins H, Collins R, Danesh J. Four Paraoxonase gene polymorphisms in 11 212 cases of coronary heart disease and 12 786 controls: Meta-analysis of 43 studies. Lancet 2004;363:689-695 (Pubitemid 38296555)
34. Mackness MI, Durrington PN, Ayub A, Mackness B. Low serum Paraoxonase: A risk factor for atherosclerotic disease? Chem Biol Interact 1999;119-120:389-397
35. Mackness MI, Durrington PN. HDL: Its enzymes and its potential to influence lipid peroxidation. Atherosclerosis 1995;115:243-253
36. Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM, et al. Protective effect of high density lipoprotein associated paraoxonase: Inhibition of the biological activity of minimally oxidised low density lipoprotein. J Clin Investig 1995;96:2882-2891
37. Mackness MI, Arrol S, Durrington PN. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoproteins. FEBS Lett 1991;286:152-154
38. Mackness B, Davis GK, Turkie W, Lee E, Roberts DH, Hill E, et al. Paraoxonase status in coronary heart disease are activity and concentration more important than genotype? Arterioscler Thromb Vasc Biol 2001;21:1451-1457
39. Mackness M, Mackness B. Paraoxonase 1 and atherosclerosis: Is the gene or the protein more important? Free Rad Biol Med 2004;37:1317-1323
40. Singh S, Venketesh S, Verma JS, Verma M, Lellamma CO, Goel RC. Paraoxonase (PON1) activity in North West Indian Punjabis with coronary artery disease and type 2 diabetes mellitus. Indian J Med Res 2007;125:783-787 (Pubitemid 47364465)
41. Sharma R, Singh B, Mahajan M. PON1 activity is inversely related to LDL apoB carbonyl content in patients with coronary artery disease. Kaohsiung J Med Sci 2007;23:225-231 (Pubitemid 46953466)
42. Sen-Banerjee S, Siles Z, Campos H. Tobacco smoking modifies association between Gln-Arg 192 polymorphism of human paraoxonase gene and risk of myocardial infarction. Arterioscler Thromb Vasc Biol 2000;20:2120-2126 (Pubitemid 30694846)